173 related articles for article (PubMed ID: 22860177)
1. ACS chemical neuroscience molecule spotlight on Begacestat (GSI-953).
Hopkins CR
ACS Chem Neurosci; 2012 Jan; 3(1):3-4. PubMed ID: 22860177
[TBL] [Abstract][Full Text] [Related]
2. Begacestat (GSI-953): a novel, selective thiophene sulfonamide inhibitor of amyloid precursor protein gamma-secretase for the treatment of Alzheimer's disease.
Martone RL; Zhou H; Atchison K; Comery T; Xu JZ; Huang X; Gong X; Jin M; Kreft A; Harrison B; Mayer SC; Aschmies S; Gonzales C; Zaleska MM; Riddell DR; Wagner E; Lu P; Sun SC; Sonnenberg-Reines J; Oganesian A; Adkins K; Leach MW; Clarke DW; Huryn D; Abou-Gharbia M; Magolda R; Bard J; Frick G; Raje S; Forlow SB; Balliet C; Burczynski ME; Reinhart PH; Wan HI; Pangalos MN; Jacobsen JS
J Pharmacol Exp Ther; 2009 Nov; 331(2):598-608. PubMed ID: 19671883
[TBL] [Abstract][Full Text] [Related]
3. Discovery of begacestat, a Notch-1-sparing gamma-secretase inhibitor for the treatment of Alzheimer's disease.
Mayer SC; Kreft AF; Harrison B; Abou-Gharbia M; Antane M; Aschmies S; Atchison K; Chlenov M; Cole DC; Comery T; Diamantidis G; Ellingboe J; Fan K; Galante R; Gonzales C; Ho DM; Hoke ME; Hu Y; Huryn D; Jain U; Jin M; Kremer K; Kubrak D; Lin M; Lu P; Magolda R; Martone R; Moore W; Oganesian A; Pangalos MN; Porte A; Reinhart P; Resnick L; Riddell DR; Sonnenberg-Reines J; Stock JR; Sun SC; Wagner E; Wang T; Woller K; Xu Z; Zaleska MM; Zeldis J; Zhang M; Zhou H; Jacobsen JS
J Med Chem; 2008 Dec; 51(23):7348-51. PubMed ID: 19012391
[TBL] [Abstract][Full Text] [Related]
4. ACS chemical neuroscience molecule spotlight on BMS-708163.
Hopkins CR
ACS Chem Neurosci; 2012 Mar; 3(3):149-50. PubMed ID: 22860183
[TBL] [Abstract][Full Text] [Related]
5. [Alzheimer's disease treatment by inhibition/modulation of the gamma-secretase activity].
Tomita T
Rinsho Shinkeigaku; 2009 Nov; 49(11):845-7. PubMed ID: 20030227
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis, and evaluation of tetrahydroquinoline and pyrrolidine sulfonamide carbamates as gamma-secretase inhibitors.
Guo T; Gu H; Hobbs DW; Rokosz LL; Stauffer TM; Jacob B; Clader JW
Bioorg Med Chem Lett; 2007 Jun; 17(11):3010-3. PubMed ID: 17418571
[TBL] [Abstract][Full Text] [Related]
7. An improved cell-based method for determining the γ-secretase enzyme activity against both Notch and APP substrates.
McKee TD; Loureiro RM; Dumin JA; Zarayskiy V; Tate B
J Neurosci Methods; 2013 Feb; 213(1):14-21. PubMed ID: 23219895
[TBL] [Abstract][Full Text] [Related]
8. Substituted 4-morpholine N-arylsulfonamides as γ-secretase inhibitors.
Zhao Z; Pissarnitski DA; Josien HB; Bara TA; Clader JW; Li H; McBriar MD; Rajagopalan M; Xu R; Terracina G; Hyde L; Song L; Zhang L; Parker EM; Osterman R; Buevich AV
Eur J Med Chem; 2016 Nov; 124():36-48. PubMed ID: 27560281
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and structure-activity relationship of a novel series of heterocyclic sulfonamide gamma-secretase inhibitors.
Pu J; Kreft AF; Aschmies SH; Atchison KP; Berkowitz J; Caggiano TJ; Chlenov M; Diamantidis G; Harrison BL; Hu Y; Huryn D; Steven Jacobsen J; Jin M; Lipinski K; Lu P; Martone RL; Morris K; Sonnenberg-Reines J; Riddell DR; Sabalski J; Sun SC; Wagner E; Wang Y; Xu Z; Zhou H; Resnick L
Bioorg Med Chem; 2009 Jul; 17(13):4708-17. PubMed ID: 19443228
[TBL] [Abstract][Full Text] [Related]
10. In vivo manifestation of Notch related phenotypes in zebrafish treated with Alzheimer's amyloid reducing gamma-secretase inhibitors.
Yang T; Arslanova D; Xu X; Li YM; Xia W
J Neurochem; 2010 Jun; 113(5):1200-9. PubMed ID: 20345767
[TBL] [Abstract][Full Text] [Related]
11. Advances in the identification of γ-secretase inhibitors for the treatment of Alzheimer's disease.
D'Onofrio G; Panza F; Frisardi V; Solfrizzi V; Imbimbo BP; Paroni G; Cascavilla L; Seripa D; Pilotto A
Expert Opin Drug Discov; 2012 Jan; 7(1):19-37. PubMed ID: 22468891
[TBL] [Abstract][Full Text] [Related]
12. γ-Secretase as a target for Alzheimer's disease.
Wolfe MS
Adv Pharmacol; 2012; 64():127-53. PubMed ID: 22840746
[TBL] [Abstract][Full Text] [Related]
13. Discovery of notch-sparing gamma-secretase inhibitors.
Augelli-Szafran CE; Wei HX; Lu D; Zhang J; Gu Y; Yang T; Osenkowski P; Ye W; Wolfe MS
Curr Alzheimer Res; 2010 May; 7(3):207-9. PubMed ID: 20088802
[TBL] [Abstract][Full Text] [Related]
14. Recent progress in the medicinal chemistry of gamma-secretase inhibitors.
Olson RE; Albright CF
Curr Top Med Chem; 2008; 8(1):17-33. PubMed ID: 18220929
[TBL] [Abstract][Full Text] [Related]
15. BMS-708,163 targets presenilin and lacks notch-sparing activity.
Crump CJ; Castro SV; Wang F; Pozdnyakov N; Ballard TE; Sisodia SS; Bales KR; Johnson DS; Li YM
Biochemistry; 2012 Sep; 51(37):7209-11. PubMed ID: 22931393
[TBL] [Abstract][Full Text] [Related]
16. Identification of gamma-secretase inhibitor potency determinants on presenilin.
Zhao B; Yu M; Neitzel M; Marugg J; Jagodzinski J; Lee M; Hu K; Schenk D; Yednock T; Basi G
J Biol Chem; 2008 Feb; 283(5):2927-38. PubMed ID: 18032377
[TBL] [Abstract][Full Text] [Related]
17. Discovery of (R)-4-cyclopropyl-7,8-difluoro-5-(4-(trifluoromethyl)phenylsulfonyl)-4,5-dihydro-1H-pyrazolo[4,3-c]quinoline (ELND006) and (R)-4-cyclopropyl-8-fluoro-5-(6-(trifluoromethyl)pyridin-3-ylsulfonyl)-4,5-dihydro-2H-pyrazolo[4,3-c]quinoline (ELND007): metabolically stable γ-secretase Inhibitors that selectively inhibit the production of amyloid-β over Notch.
Probst G; Aubele DL; Bowers S; Dressen D; Garofalo AW; Hom RK; Konradi AW; Marugg JL; Mattson MN; Neitzel ML; Semko CM; Sham HL; Smith J; Sun M; Truong AP; Ye XM; Xu YZ; Dappen MS; Jagodzinski JJ; Keim PS; Peterson B; Latimer LH; Quincy D; Wu J; Goldbach E; Ness DK; Quinn KP; Sauer JM; Wong K; Zhang H; Zmolek W; Brigham EF; Kholodenko D; Hu K; Kwong GT; Lee M; Liao A; Motter RN; Sacayon P; Santiago P; Willits C; Bard F; Bova MP; Hemphill SS; Nguyen L; Ruslim L; Tanaka K; Tanaka P; Wallace W; Yednock TA; Basi GS
J Med Chem; 2013 Jul; 56(13):5261-74. PubMed ID: 23713656
[TBL] [Abstract][Full Text] [Related]
18. Design, synthesis and structure-activity relationship of novel [3.3.1] bicyclic sulfonamide-pyrazoles as potent γ-secretase inhibitors.
Aubele DL; Truong AP; Dressen DB; Probst GD; Bowers S; Mattson MN; Semko CM; Sun M; Garofalo AW; Konradi AW; Sham HL; Zmolek W; Wong K; Goldbach E; Quinn KP; Sauer JM; Brigham EF; Wallace W; Nguyen L; Bova MP; Hemphill SS; Basi G
Bioorg Med Chem Lett; 2011 Oct; 21(19):5791-4. PubMed ID: 21885276
[TBL] [Abstract][Full Text] [Related]
19. Structural basis of γ-secretase inhibition and modulation by small molecule drugs.
Yang G; Zhou R; Guo X; Yan C; Lei J; Shi Y
Cell; 2021 Jan; 184(2):521-533.e14. PubMed ID: 33373587
[TBL] [Abstract][Full Text] [Related]
20. ACS chemical neuroscience molecule spotlight on ELND006: another γ-secretase inhibitor fails in the clinic.
Hopkins CR
ACS Chem Neurosci; 2011 Jun; 2(6):279-80. PubMed ID: 22778871
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
